Sanofi US (FKA Sanofi-Aventis)

Registered Principal Details

Business Or Interest:
Pharmaceutical Manufacturing

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.

CEO Name:
Jez Moulding
Head

Contact
DC
Deanne Calvert
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
deanne.calvert@sanofi.com
http://www.sanofi.us

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 679
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

For
Notification Date
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

2017 Wisconsin Act 149

For
Notification Date
11/22/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

2019-21 State Budget Bill
Development, drafting or introduction of a proposal relating to
2019-21 State Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

The availability of the flu vaccine in hospitals and nursing homes
Development, drafting or introduction of a proposal relating to
The availability of the flu vaccine in hospitals and nursing homes

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health and immunization standards
Development, drafting or introduction of a proposal relating to
Health and immunization standards

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Development, drafting or introduction of a proposal relating to
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Prevention and wellness initiatives
Development, drafting or introduction of a proposal relating to
Prevention and wellness initiatives

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Biosimilars substitution
Development, drafting or introduction of a proposal relating to
Biosimilars substitution

Action Intended To Affect
Legislative matter

Notification Date
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Meningococcal vaccine school entry requirement recommendations
Development, drafting or introduction of a proposal relating to
Meningococcal vaccine school entry requirement recommendations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Biosimilars
Development, drafting or introduction of a proposal relating to
Biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Pharmaceuticals pricing
Development, drafting or introduction of a proposal relating to
Pharmaceuticals pricing

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$0.00
2017
July - December
$12,057.50
2018
January - June
$29,192.98
2018
July - December
$13,273.20
Total $54,523.68
Total Hours Communicating 2017
January - June
0.00
2017
July - December
27.50
2018
January - June
24.40
2018
July - December
9.00
Total 60.90
Total Hours Other 2017
January - June
0.00
2017
July - December
13.00
2018
January - June
23.50
2018
July - December
8.70
Total 45.20

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30%
2018
January - June
20%
2018
July - December
Total 21%
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30%
2018
January - June
20%
2018
July - December
Total 21%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
2018
July - December
15%
Total 6%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
20%
2018
January - June
2018
July - December
25%
Total 12%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
50%
2018
July - December
25%
Total 27%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
2018
July - December
25%
Total 4%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
5%
2018
July - December
10%
Total 8%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
100%
2017
July - December
2018
January - June
5%
2018
July - December
Total 2%

Filed Statements of Lobbying Activity and Expenditures